Global Drugmakers Invest Billions to Expand US Manufacturing and R&D

Key facts

• Major pharmaceutical companies are committing billions to expand U.S. manufacturing and R&D.
• Pfizer, Eli Lilly, and AstraZeneca are among the companies investing in the U.S.
• Investments aim to bolster U.S. infrastructure and mitigate supply chain risks.
• Bristol Myers Squibb will invest $2.3 billion in a new Houston, Texas manufacturing site.
• The Bristol Myers Squibb facility is expected to create nearly 500 skilled jobs.
• The Houston site will focus on small-molecule medicines and complex drugs.
• Mining investor TechMet formed a U.S. subsidiary to attract capital for critical minerals projects.
• TechMet is a Dublin-based company with the U.S. government as a major shareholder.
• TechMet aims to boost domestic production and processing of critical minerals.

Major pharmaceutical companies are significantly increasing their investment in the United States, committing billions of dollars to expand manufacturing capacity and research and development operations. Companies like Pfizer, Eli Lilly, and AstraZeneca are leading this trend, aiming to strengthen domestic infrastructure and reduce reliance on global supply chains, particularly in light of evolving trade policies.

Bristol Myers Squibb has announced a substantial investment of approximately $2.3 billion to establish a new manufacturing facility in Houston, Texas. This facility is slated to create nearly 500 skilled jobs and will specialize in the production of small-molecule medicines and complex drug formulations. The expansion by these pharmaceutical giants underscores a broader movement to onshore critical industries.

In a related development concerning domestic resource production, mining investor TechMet has established a U.S. subsidiary. This move is intended to attract capital for critical minerals projects within the United States. TechMet, a Dublin-based company with the U.S. government as a significant shareholder, seeks to enhance domestic production and processing capabilities for essential minerals.